326 related articles for article (PubMed ID: 30665678)
21. Antisense lncRNA FOXF1-AS1 Promotes Migration and Invasion of Osteosarcoma Cells Through the FOXF1/MMP-2/-9 Pathway.
Kun-Peng Z; Chun-Lin Z; Xiao-Long M
Int J Biol Sci; 2017; 13(9):1180-1191. PubMed ID: 29104509
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of the long non‑coding RNA FOXD2‑AS1 inhibits cell proliferation, migration and invasion in osteosarcoma.
Zhang H; Lu Y; Wang J; Zhang T; Dong C; Li X; Wang X; Ma Q; Yang T; Zhou Y
Mol Med Rep; 2019 Jul; 20(1):292-302. PubMed ID: 31115575
[TBL] [Abstract][Full Text] [Related]
23. A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma.
Zhang CL; Zhu KP; Shen GQ; Zhu ZS
Tumour Biol; 2016 Feb; 37(2):2737-48. PubMed ID: 26408180
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA HOTTIP is up-regulated and associated with poor prognosis in patients with osteosarcoma.
Li F; Cao L; Hang D; Wang F; Wang Q
Int J Clin Exp Pathol; 2015; 8(9):11414-20. PubMed ID: 26617868
[TBL] [Abstract][Full Text] [Related]
25. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
Li G; Liu K; Du X
Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
[TBL] [Abstract][Full Text] [Related]
26. ELK1-induced upregulation of long non-coding RNA MIR100HG predicts poor prognosis and promotes the progression of osteosarcoma by epigenetically silencing LATS1 and LATS2.
Su X; Teng J; Jin G; Li J; Zhao Z; Cao X; Guo Y; Guo M; Li X; Wu J; Wang C; Guo Z; Guo Q
Biomed Pharmacother; 2019 Jan; 109():788-797. PubMed ID: 30551532
[TBL] [Abstract][Full Text] [Related]
27. LncRNA MIAT facilitates osteosarcoma progression by regulating mir-128-3p/VEGFC axis.
Zhang C; Xie L; Liang H; Cui Y
IUBMB Life; 2019 Jul; 71(7):845-853. PubMed ID: 30629798
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy.
Wang Z; Liu Z; Wu S
Oncotarget; 2017 May; 8(19):31465-31477. PubMed ID: 28415557
[TBL] [Abstract][Full Text] [Related]
29. Effect of lncRNA LET on proliferation and invasion of osteosarcoma cells.
Kong G; Qi XJ; Wang JF
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1609-1614. PubMed ID: 29630103
[TBL] [Abstract][Full Text] [Related]
30. DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression.
Li X; Na H; Xu L; Zhang X; Feng Z; Zhou X; Cui J; Zhang J; Lin F; Yang S; Yue F; Mousa H; Zuo Y
Biomed Pharmacother; 2020 Jan; 121():109644. PubMed ID: 31766099
[TBL] [Abstract][Full Text] [Related]
31. TCF3-activated LINC00152 exerts oncogenic role in osteosarcoma through regulating miR-1182/CDK14 axis.
Zheng L; Hu N; Zhou X
Pathol Res Pract; 2019 Feb; 215(2):373-380. PubMed ID: 30600185
[TBL] [Abstract][Full Text] [Related]
32. LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma.
Wang Y; Zhao Z; Zhang S; Li Z; Li D; Yang S; Zhang H; Zeng X; Liu J
J Cell Biochem; 2018 Nov; 119(10):8481-8489. PubMed ID: 29987852
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of long non-coding RNA MFI2 promotes cell proliferation and suppresses apoptosis in human osteosarcoma.
Yin Z; Ding H; He E; Chen J; Li M
Oncol Rep; 2016 Oct; 36(4):2033-40. PubMed ID: 27513470
[TBL] [Abstract][Full Text] [Related]
34. LncRNA, CRNDE promotes osteosarcoma cell proliferation, invasion and migration by regulating Notch1 signaling and epithelial-mesenchymal transition.
Li Z; Tang Y; Xing W; Dong W; Wang Z
Exp Mol Pathol; 2018 Feb; 104(1):19-25. PubMed ID: 29246789
[TBL] [Abstract][Full Text] [Related]
35. LncRNA CCAT2 enhances cell proliferation via GSK3β/β-catenin signaling pathway in human osteosarcoma.
Ruan R; Zhao XL
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2978-2984. PubMed ID: 29863240
[TBL] [Abstract][Full Text] [Related]
36. LncRNA-SRA1 Suppresses Osteosarcoma Cell Proliferation While Promoting Cell Apoptosis.
Guo W; Jiang H; Li H; Li F; Yu Q; Liu Y; Jiang W; Zhang M
Technol Cancer Res Treat; 2019 Jan; 18():1533033819841438. PubMed ID: 31106680
[TBL] [Abstract][Full Text] [Related]
37.
Luo Y; Tao H; Jin L; Xiang W; Guo W
Cancer Biother Radiopharm; 2020 Feb; 35(1):58-65. PubMed ID: 31724892
[No Abstract] [Full Text] [Related]
38. Long Noncoding RNA XIST Promotes Osteosarcoma Progression by Targeting Ras-Related Protein RAP2B via miR-320b.
Lv GY; Miao J; Zhang XL
Oncol Res; 2018 Jul; 26(6):837-846. PubMed ID: 28409547
[TBL] [Abstract][Full Text] [Related]
39. LncRNA ODRUL Contributes to Osteosarcoma Progression through the miR-3182/MMP2 Axis.
Zhu KP; Ma XL; Zhang CL
Mol Ther; 2017 Oct; 25(10):2383-2393. PubMed ID: 28750740
[TBL] [Abstract][Full Text] [Related]
40. The LINC01410/miR-122-5p/NDRG3 axis is involved in the proliferation and migration of osteosarcoma cells.
Ma W; Zhao X; Xue N; Gao Y; Xu Q
IUBMB Life; 2021 Apr; 73(4):705-717. PubMed ID: 33583123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]